Cronos Group Stock Price To Sales
| CRON Stock | CAD 2.72 0.07 2.51% |
Cronos Group fundamentals help investors to digest information that contributes to Cronos' financial success or failures. It also enables traders to predict the movement of Cronos Stock. The fundamental analysis module provides a way to measure Cronos' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Cronos stock.
| Last Reported | Projected for Next Year | ||
| Price To Sales Ratio | 9.12 | 8.66 |
Cronos | Price To Sales |
Cronos Group Company Price To Sales Analysis
Cronos' Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Current Cronos Price To Sales | 10.22 X |
Most of Cronos' fundamental indicators, such as Price To Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Cronos Group is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Cronos Price To Sales Driver Correlations
Understanding the fundamental principles of building solid financial models for Cronos is extremely important. It helps to project a fair market value of Cronos Stock properly, considering its historical fundamentals such as Price To Sales. Since Cronos' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Cronos' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Cronos' interrelated accounts and indicators.
Click cells to compare fundamentals
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
| Competition |
Cronos Price To Sales Ratio
Price To Sales Ratio |
|
Based on the latest financial disclosure, Cronos Group has a Price To Sales of 10.2171 times. This is 52.26% lower than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The price to sales for all Canada stocks is 10.53% higher than that of the company.
Cronos Price To Sales Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Cronos' direct or indirect competition against its Price To Sales to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Cronos could also be used in its relative valuation, which is a method of valuing Cronos by comparing valuation metrics of similar companies.Cronos is currently under evaluation in price to sales category among its peers.
Cronos Current Valuation Drivers
We derive many important indicators used in calculating different scores of Cronos from analyzing Cronos' financial statements. These drivers represent accounts that assess Cronos' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Cronos' important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 3.4B | 2.4B | 1.5B | 939.9M | 795.6M | 946.8M | |
| Enterprise Value | 2.2B | 1.3B | 578.5M | 179.2M | 128.8M | 122.4M |
Cronos Fundamentals
| Return On Equity | -0.0529 | ||||
| Return On Asset | -0.0373 | ||||
| Profit Margin | (0.56) % | ||||
| Operating Margin | (0.54) % | ||||
| Current Valuation | (157.93 M) | ||||
| Shares Outstanding | 382.3 M | ||||
| Shares Owned By Insiders | 46.40 % | ||||
| Shares Owned By Institutions | 15.61 % | ||||
| Number Of Shares Shorted | 4.57 M | ||||
| Price To Earning | 20.66 X | ||||
| Price To Book | 0.69 X | ||||
| Price To Sales | 10.22 X | ||||
| Revenue | 87.24 M | ||||
| Gross Profit | 11.97 M | ||||
| EBITDA | (71.8 M) | ||||
| Net Income | (74.55 M) | ||||
| Cash And Equivalents | 764.64 M | ||||
| Cash Per Share | 3.34 X | ||||
| Total Debt | 2.55 M | ||||
| Debt To Equity | 0.01 % | ||||
| Current Ratio | 4.36 X | ||||
| Book Value Per Share | 2.88 X | ||||
| Cash Flow From Operations | (42.84 M) | ||||
| Short Ratio | 51.99 X | ||||
| Earnings Per Share | (0.17) X | ||||
| Price To Earnings To Growth | (0.54) X | ||||
| Target Price | 3.57 | ||||
| Number Of Employees | 356 | ||||
| Beta | 1.01 | ||||
| Market Capitalization | 1.04 B | ||||
| Total Asset | 1.14 B | ||||
| Retained Earnings | 416.72 M | ||||
| Working Capital | 891.91 M | ||||
| Net Asset | 1.14 B |
About Cronos Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Cronos Group's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cronos using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cronos Group based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
When determining whether Cronos Group offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cronos' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cronos Group Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cronos Group Stock: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cronos Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.